about
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform ba...
Read More
2.67
-0.04
(-1.48%)
823.0K
XNAS Volume
XNAS 12 Sep, 2025 1:58 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Editas Medicine Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..